COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,755 Articles (22,943 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 2049: Articles 20481-20490  | Next

Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis
Crespo-Facorro, B., Ruiz-Veguilla, M., Vazquez-Bourgon, J., Sanchez-Hidalgo, A. C., Garrido-Torres, N., Cisneros, J. M., Prieto, C., Sainz, J.
10.1101/2020.12.05.20244590 — Posted: 2020-12-07
Self-harm and the COVID-19 pandemic: a study of factors contributing to self-harm during lockdown restrictions
Hawton, K., Lascelles, K., Brand, F., Casey, D., Bale, E., Ness, J., Kelly, S., Waters, K.
10.1101/2020.12.04.20244129 — Posted: 2020-12-07
Epidemic Progression and Vaccination in a Heterogeneous Population. Application to the Covid-19 epidemic
Volpert, V., Banerjee, M., Sharma, S.
10.1101/2020.12.06.20244731 — Posted: 2020-12-07
Seasonality and Progression of COVID-19 among Countries With or Without Lock-downs.
Sagripanti, D. J.-L.
10.1101/2020.12.06.20244780 — Posted: 2020-12-07
Rt2: computing and visualising COVID-19 epidemics temporal reproduction number
Reyne, B., Danesh, G., Alizon, S., Sofonea, M. T.
10.1101/2020.12.05.20244376 — Posted: 2020-12-07
Indicators of COVID-19 status in a cohort study of university staff and post-graduate research students, including results from home antibody testing
Davis, K. A. S., Carr, E., Leightley, D., Vitiello, V., Cartwright, G. B., Lavelle, G., Wickersham, A., Malim, M. H., Oetzmann, C., Polling, C., Stevelink, S. A. M., Razavi, R., Hotopf, M., KCL-CHECK research team
10.1101/2020.12.07.20245183 — Posted: 2020-12-07
A new, simple method of describing COVID-19 trajectory and dynamics in any country based on Johnson Cumulative Distribution Function fitting.
Cmiel, A. M., Cmiel, B.
10.1101/2020.12.05.20244178 — Posted: 2020-12-07
Selectively caring for the most severe COVID-19 patients delays ICU bed shortages more than increasing hospital capacity
Roberts, M. D., Seymour, H. D., Dimitrov, A.
10.1101/2020.12.05.20222968 — Posted: 2020-12-07
Seroconversion stages COVID19 into distinct pathophysiological states
Galbraith, M. D., Kinning, K. T., Sullivan, K. D., Baxter, R., Araya, P., Jordan, K. R., Russell, S., Smith, K. P., Granrath, R. E., Shaw, J. R., Dzieciatkowska, M., Ghosh, T., Monte, A. A., D'Alessandro, A., Hansen, K. C., Bennett, T. D., Hsieh, E. W. Y., Espinosa, J. M.
10.1101/2020.12.05.20244442 — Posted: 2020-12-07
Sensitive detection and quantification of SARS-CoV-2 in saliva
Abasiyanik, M. F., Flood, B., Lin, J., Ozcan, S., Rouhani, S., Pyzer, A., Trujillo, J., Zhen, C., Wu, P., Jumic, S., Wang, A., Gajewski, T., Wang, P., Hartley, M., Ameti, B., Niemiec, R., Fernando, M., Aydogan, B., Bethel, C., Matushek, S., Beavis, K., Agrawal, N., Segal, J., Tay, S., Izumchenko, E.
10.1101/2020.12.04.20241059 — Posted: 2020-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).